Skip to main content

Who We Are

The Breast Medical Oncology group at UNC strives to give the best, most evidence-based, cutting-edge, and compassionate care possible.

We believe that every patient walking through our doors should receive the same care that we would desire for ourselves or our family members. We partner with our patients to provide care that is effective in treating their cancer while also helping to maintain their quality of life and holistic well-being. The Breast Medical Oncology department works as a team made up of Oncology Physicians, Nurse Practitioners and Physician Assistants (also called Advanced Practice Providers), Oncology Fellows, Pharmacists, Oncology Nurse Navigators and clinic nurses, phone nurses, and certified medical assistants, working together to ensure that our team is always available when you need us.

We communicate regularly about each of our patients and their care.  Additionally, we hold weekly multidisciplinary meetings with our colleagues in radiology, pathology, surgical oncology, genetics, and radiation oncology to ensure that all patients receive timely, coordinated care.

Breast Cancer Care Team


Advanced Practice Providers

Nurse Navigators

Clinical Oncology Pharmacist

What Types of Breast Cancer Do We Treat?

Our multi-disciplinary team has expertise in the treatment of all breast cancer sub-types, including:

  • Hormone Receptor (estrogen and/or progesterone) positive breast cancer
  • HER2 positive, or over-expressing, breast cancer
  • Triple negative breast cancer
  • Metastatic breast cancer

How We Treat Breast Cancer:

Our team attends multiple national and international research meetings each year to stay up to date with the latest innovations in breast cancer care.  Following national guidelines and the results of ground-breaking new research as it becomes available, we use a combination of therapies to treat breast cancer, including:

  • Endocrine Therapy
  • Chemotherapy
  • Immunotherapy
  • Targeted therapies based on genetic/genomic testing
  • Clinical trials across the cancer care continuum
  • Survivorship care

Our Research & Clinical Trials

Our physicians are faculty members of the UNC School of Medicine and include leaders across multiple areas of breast cancer research, including breast cancer genomics with a focus on triple negative disease, drug discovery and early phase clinical research, large clinical trials of new treatments, geriatric oncology, and cancer care delivery research with a focus on improving the equity of breast cancer care.

A central focus of our research program is the National Cancer Institute-funded Specialized Program of Research Excellence (SPORE) in Breast Cancer.  One of only six Breast Cancer SPORE programs in the country, the NCI designation recognizes UNC Breast Care for its efforts to promote collaborative, interdisciplinary and translational cancer research.

Originally funded in 1992, the UNC SPORE in Breast Cancer has created an outstanding program in translational research. Current focuses of the SPORE program include genetic susceptibility for breast cancer subtypes in Black and White patients, targeting infiltrating immune cells in claudin-low and basal-type tumors, development of new therapeutic targets in triple negative breast cancers, and defining kinome activity for development of novel breast cancer therapies.  The SPORE also supports the career development of the next generation of breast cancer researchers.

Other Important Services We Offer

Our team works closely with experts across the Lineberger Comprehensive Cancer Center to address every aspect of living with breast cancer including: